8 citations as recorded by crossref.

1. Subcutaneous zilucoplan: Evaluation of reproductive toxicology M. Lemper et al. https://doi.org/10.1016/j.reprotox.2025.108877
2. Enhanced normograms and pregnancy outcome analysis in nonhuman primate developmental toxicity studies H. Grossmann et al. https://doi.org/10.1016/j.reprotox.2020.04.074
3. Assessing the impact and risk of immunomodulatory compounds on pregnancy J. Kwak-Kim et al. https://doi.org/10.1016/j.jri.2025.104453
4. Intravitreal RTH258 (brolucizumab) demonstrates no effect on pregnancy, parturition, embryofetal or postnatal development in cynomolgus monkeys H. Booler et al. https://doi.org/10.1016/j.reprotox.2023.108468
5. Minimizing use of nonhuman primates to inform risk to fertility and of adverse pregnancy outcomes with pharmaceuticals C. Bowman et al. https://doi.org/10.1016/j.yrtph.2025.105971
6. Alternatives to Monkey Reproductive Toxicology Testing for Biotherapeutics A. Hoberman et al. https://doi.org/10.1177/10915818231200859
7. Evaluation of the effect of rozanolixizumab on pregnancy outcomes and pre- and postnatal development in cynomolgus monkeys A. Cauvin et al. https://doi.org/10.1016/j.reprotox.2024.108823
8. Enhanced pre- and postnatal developmental toxicity (ePPND) study in non-human primates: Necessity, strategic approaches, and critical considerations J. Lu et al. https://doi.org/10.1016/j.yrtph.2025.105814